Kezar Life Sciences (NASDAQ:KZR) Price Target Cut to $7.00 by Analysts at HC Wainwright
Kezar Life Sciences (NASDAQ:KZR – Free Report) had its price target trimmed by HC Wainwright from $20.00 to $7.00 in a report issued on Monday, Benzinga reports. The firm currently has a buy rating on the stock. Kezar Life Sciences Price Performance KZR stock opened at $0.66 on Monday. Kezar Life Sciences has a 1 […]
More Stories
Take Charge of My Heart: Release Date, Trailer, Plot, and More
Are you also hunting for the next Korean romantic-comedy drama? Then your search ends here. Take Charge of My Heart...
Minerva Academy: Release Date, Plot, Cast, Trailer, and More
Netflix’s latest Italian drama Minerva Academy is currently streaming online on the popular streaming network Netflix. Its original title is...
8 Best Commercial Skylight Companies for US Projects (2026)
Getting commercial daylighting wrong is expensive in a way residential work rarely is. A leaking curb on a house is...
Is Sweet Magnolias Season 6 Renewed? Latest News and Review
Netflix’s romantic drama Sweet Magnolias has finally come to an end. In September 2026, Deadline officially announced that one of...
The Inbetweeners 3: Release Date, Cast, Trailer, and Updates
The Inbetweeners 3 is finally coming back on the popular streaming Network, Netflix. The original four stars of the series,...
7 Essential Components of a Modern Corporate Training Tech Stack
What the seven components need to accomplish Your LMS isn’t obsolete. It may simply need to play one part in...